Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ZBIO
ZBIO logo

ZBIO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ZBIO News

Executive Stock Purchase Activity

6d agoYahoo Finance

Stock Futures Rise as Trump Delays Military Action Against Iran

Mar 27 2026seekingalpha

Zenas BioPharma Completes $300 Million Dual Offering

Mar 27 2026seekingalpha

Zenas BioPharma Prices $200 Million Convertible Notes Offering

Mar 27 2026Newsfilter

Zenas BioPharma Launches Convertible Note Offerings

Mar 26 2026seekingalpha

ENAVATE Increases Stake in Zenas BioPharma

Mar 21 2026Fool

Zenas BioPharma Reports Q4 EPS Miss and Cash Projections

Mar 16 2026seekingalpha

Purcell & Lefkowitz Investigates Zenas BioPharma for Potential Fiduciary Breaches

Feb 17 2026PRnewswire

ZBIO Events

03/27 07:50
Common Stock Offering Increased to $100M, Priced Below $22.16
The common stock offering was increased to $100M and priced below last closing price of $22.16. Jefferies, Evercore ISI, Citi and Guggenheim are acting as joint book running managers for the offering.
03/26 19:10
Nasdaq Index Enters Correction Territory as Energy Prices Rise
Check out this evening's top movers from around Wall Street, compiled by The Fly.Hopes for a near-term resolution to U.S.-Iran standoff continue to fade with more saber-rattling comments out of both sides, denting equity markets that are already reeling from internal challenges while goosing up energy prices.  Thursday's market action was decidedly negative as Nasdaq Composite index also officially closed in "correction" territory - down by over 10% from its February highs.  Communication Services sector was especially hard-hit as the sector's top two stocks - Alphabetand Meta- fell 3% and 8% respectively in the wake of an adverse court ruling regarding social media addiction.  Those stocks are now down 10% and 17% year-to-date, while the State Street Communication Services ETF, of which they are the top two holdings, is down 10% from the highs.In the opening hour of the evening session, S&P 500 and Nasdaq 100 futures contracts are up 0.3% following Truth Social post by Trump that Iran would be granted another extension until its energy infrastructure assets are bombed, though that bounce is fairly shallow after the 1.7% and 2.4% declines in the respective indices on Thursday.  WTI Crude Oil trades just above $93 per barrel - off the Thursday highs above $95.50 but also well off the lows near $90 seen after the Trump post, with traders consistently fading the president's attempts to signal a path toward de-escalation.HIGHER AFTER EARNINGS -Arganup 9.5%Newsmaxup 5.5%ALSO HIGHER -Unity Softwareup 14.4% after raising Q1 revenue guidanceSIGA Technologiesup 9.9% after declaring special dividendDOWN AFTER EARNINGS -Laird Superfooddown 11.0%P3 Health Partnersdown 6.8%ALSO LOWER -Lithium Argentinadown 11.4% after block saleZenas BioPharmadown 9.8% after equity offering
03/26 16:10
Zenas BioPharma Launches Underwritten Public Offerings of Convertible Notes and Common Stock
Zenas BioPharma announced that it has commenced underwritten public offerings of its convertible senior notes due 2032 and shares of its common stock. Jefferies, Evercore ISI, Citigroup and Guggenheim Securities are acting as joint book-running managers for the proposed convertible notes oOffering and proposed equity offering. Wedbush PacGrow is acting as co-manager for the proposed convertible notes offering and proposed equity offering.

ZBIO Monitor News

Zenas Biopharma stock drops 56% despite positive trial results

Jan 05 2026

ZBIO Earnings Analysis

No Data

No Data

People Also Watch